Patent · US Expired

Use of a peptide

US5631224A · kind A · utility

163Cited by
0References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 13, 1994
Grant dateMay 20, 1997
Priority date
Expiry dateOct 13, 2014

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P3/10
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention employs GLP-1(7-37), GLP-1(7-36)amide, and certain related compounds in combination with an oral hypoglycaemic agent for treating diabetes mellitus.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.